Furthermore!Morningstar had a Fair Value sp of $.97 and a speculative 1-star valuation of $6.91 after market close yesterday. If the testing goes as expected and the applications for governmental review are submitted, it's impossible to believe this will be south of $1.00 again.
Remember as well that once the device is established it could be much more easily and cheaply modified for any number of viral pathogens (influenza, viral pneumonia to name two).
There is much to happen here yet!
Cheers and GLTA!